You're almost done! We just need to verify your account before you canstart using it.
Note: Rediff will never share your number with any company for marketing purpose.
Rediff Buy with a target of Rs 350 & stop loss of Rs 319- Prakash Gaba, technical analyst. (ET Now) #money
Marina Boseyes :-*
Digbijay Elder Pharma is very good company in long run #money
Digbijay Can take position now 30 for next 3 days #money
rK [SKB] Buy for a tgt of 450 by next week with stop loss @252.
rK Buy for a tgt of 450 by next week with stop loss @252.
rK Buy for strong upside on Monday above 300. #money
rKfirst tgt met.
Rediff says it will not proceed with amalgamation of Elder Health Care with company. (CNBC TV18) #money
Anil Kumar Sell for 210 SL 265 #money
Sanjay PatelBuy Buy...Buy..................Trg.........315 in Next week
Anil KumarTarget Achieved
Rediff : Promoters have not sold any share of the company. (ET Now) #money
Rediff Ratnakar Bank sold 1.4 lakh shares of on Saturday at Rs 320/share; promoter pledge at 80%. (CNBC TV18) #money